Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of sacubitril-valsartan in patients undergoing maintenance dialysis
Ying Ding, Li Wan, Zhoucang Zhang, et al.
Renal Failure (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Efficacy and safety of sacubitril-valsartan in hypertension patients with end-stage kidney disease on maintenance dialysis: a meta-analysis
Nguyễn Việt Dũng, Giang Thai Pham, Son Pham, et al.
Journal of Hypertension (2025)
Closed Access
Impact of sacubitril/valsartan on adverse clinical events in heart failure with end-stage renal disease patients—a real life nationwide investigation
Wei‐Syun Hu, Cheng‐Li Lin
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Sacubitril-Valsartan in Patients Requiring Hemodialysis
Dustin Le, Morgan E. Grams, Josef Coresh, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2429237-e2429237
Open Access | Times Cited: 3
Effect of Sacubitril/Valsartan on Patients Having Heart Failure With Preserved Left Ventricular Ejection Fraction Undergoing Hemodialysis: A Long-term Observational Study
Akira Mima, Hidemasa Gotoda, Shinji Lee, et al.
In Vivo (2024) Vol. 38, Iss. 3, pp. 1266-1270
Open Access | Times Cited: 2
Benefits of sacubitril/valsartan administration and physical training in cardiac rehabilitation: current trends and bibliometric analysis of the years 2015-2024
Diana Carina Iovanovici, Bombonica Gabriela Dogaru, Carmen Delia Nistor-Cseppento, et al.
Balneo and PRM Research Journal (2024) Vol. 15, Iss. Vol.15, no. 2, pp. 683-683
Open Access | Times Cited: 2
Incidence of hyperkalemia in anuric hemodialysis patients treated with sacubitril/valsartan
Xiaofan Li, Fei Ma, Yan Wang, et al.
Hemodialysis International (2024) Vol. 28, Iss. 3, pp. 336-342
Closed Access | Times Cited: 1
Angiotensin receptor neprilysin inhibitor in chronic heart failure and comorbidity management: Indian consensus statement
Sanjay Mittal, Sivadasanpillai Harikrishnan, Anoop K. Gupta, et al.
Therapeutic Advances in Cardiovascular Disease (2024) Vol. 18
Open Access | Times Cited: 1
HIỆU QUẢ HẠ HUYẾT ÁP CỦA SACUBITRIL/VALSARTAN Ở BỆNH NHÂN LỌC MÁU NGOÀI THẬN CÓ TĂNG HUYẾT ÁP: KẾT QUẢ TỪ NGHIÊN CỨU PHÂN TÍCH GỘP
Việt Dũng Nguyễn, Thiêm Đông Hà, Thị Thu Hoài Nguyễn
Tạp chí Y học Việt Nam (2024) Vol. 534, Iss. 1B
Open Access
Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path
Luxuan Guo, Yue Ji, Tianhao Sun, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 6, pp. 232-232
Open Access
Safety and efficacy of angiotensin receptor neprilysin inhibitor in improving cardiac function and blood pressure in dialysis patients
Kai Zhou, Qiuyue Zhang, Wen Ying Dong, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Angiotensin Receptor-Neprilysin Inhibitor for Chronic Kidney Disease: Strategies for Renal Protection
Erika Hishida, Daisuke Nagata
Kidney & Blood Pressure Research (2024) Vol. 49, Iss. 1, pp. 916-932
Open Access
The impact of angiotensin-receptor neprilysin inhibitors on cardiovascular events and solute transport function in peritoneal dialysis patients: a multicenter retrospective controlled study
Yishu Wang, Canxin Zhou, Xiaoyan Ma, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access
Page 1

Scroll to top